Cargando…

Biological function and research progress of N (6)-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers

N(6)-methyladenosine (m(6)A) is the most prevalent internal modification found in both mRNA and lncRNA. It exerts reversible regulation over RNA function and affects RNA processing and metabolism in various diseases, especially tumors. The m(6)A binding protein, hnRNPA2B1, is extensively studied as...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yue, Li, An, Chen, Can, Fang, Zhang, Chen, Lujun, Zheng, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399595/
https://www.ncbi.nlm.nih.gov/pubmed/37546413
http://dx.doi.org/10.3389/fonc.2023.1229168
_version_ 1785084277789032448
author Wu, Yue
Li, An
Chen, Can
Fang, Zhang
Chen, Lujun
Zheng, Xiao
author_facet Wu, Yue
Li, An
Chen, Can
Fang, Zhang
Chen, Lujun
Zheng, Xiao
author_sort Wu, Yue
collection PubMed
description N(6)-methyladenosine (m(6)A) is the most prevalent internal modification found in both mRNA and lncRNA. It exerts reversible regulation over RNA function and affects RNA processing and metabolism in various diseases, especially tumors. The m(6)A binding protein, hnRNPA2B1, is extensively studied as a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) protein family. It is frequently dysregulated and holds significant importance in multiple types of tumors. By recognizing m(6)A sites for variable splicing, maintaining RNA stability, and regulating translation and transport, hnRNPA2B1 plays a vital role in various aspects of tumor development, metabolism, and regulation of the immune microenvironment. In this review, we summarized the latest research on the functional roles and underlying molecular mechanisms of hnRNPA2B1. Moreover, we discussed its potential as a target for tumor therapy.
format Online
Article
Text
id pubmed-10399595
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103995952023-08-04 Biological function and research progress of N (6)-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers Wu, Yue Li, An Chen, Can Fang, Zhang Chen, Lujun Zheng, Xiao Front Oncol Oncology N(6)-methyladenosine (m(6)A) is the most prevalent internal modification found in both mRNA and lncRNA. It exerts reversible regulation over RNA function and affects RNA processing and metabolism in various diseases, especially tumors. The m(6)A binding protein, hnRNPA2B1, is extensively studied as a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) protein family. It is frequently dysregulated and holds significant importance in multiple types of tumors. By recognizing m(6)A sites for variable splicing, maintaining RNA stability, and regulating translation and transport, hnRNPA2B1 plays a vital role in various aspects of tumor development, metabolism, and regulation of the immune microenvironment. In this review, we summarized the latest research on the functional roles and underlying molecular mechanisms of hnRNPA2B1. Moreover, we discussed its potential as a target for tumor therapy. Frontiers Media S.A. 2023-07-20 /pmc/articles/PMC10399595/ /pubmed/37546413 http://dx.doi.org/10.3389/fonc.2023.1229168 Text en Copyright © 2023 Wu, Li, Chen, Fang, Chen and Zheng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wu, Yue
Li, An
Chen, Can
Fang, Zhang
Chen, Lujun
Zheng, Xiao
Biological function and research progress of N (6)-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers
title Biological function and research progress of N (6)-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers
title_full Biological function and research progress of N (6)-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers
title_fullStr Biological function and research progress of N (6)-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers
title_full_unstemmed Biological function and research progress of N (6)-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers
title_short Biological function and research progress of N (6)-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers
title_sort biological function and research progress of n (6)-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein a2b1 in human cancers
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399595/
https://www.ncbi.nlm.nih.gov/pubmed/37546413
http://dx.doi.org/10.3389/fonc.2023.1229168
work_keys_str_mv AT wuyue biologicalfunctionandresearchprogressofn6methyladenosinebindingproteinheterogeneousnuclearribonucleoproteina2b1inhumancancers
AT lian biologicalfunctionandresearchprogressofn6methyladenosinebindingproteinheterogeneousnuclearribonucleoproteina2b1inhumancancers
AT chencan biologicalfunctionandresearchprogressofn6methyladenosinebindingproteinheterogeneousnuclearribonucleoproteina2b1inhumancancers
AT fangzhang biologicalfunctionandresearchprogressofn6methyladenosinebindingproteinheterogeneousnuclearribonucleoproteina2b1inhumancancers
AT chenlujun biologicalfunctionandresearchprogressofn6methyladenosinebindingproteinheterogeneousnuclearribonucleoproteina2b1inhumancancers
AT zhengxiao biologicalfunctionandresearchprogressofn6methyladenosinebindingproteinheterogeneousnuclearribonucleoproteina2b1inhumancancers